NCT04488497 Cardiovascular Risk Assessment for Patients With Rheumatoid Arthritis Arthritis: Status COMPLETED Phase NA
NCT04482335 PRECISion medicinE Across the Disease Continuum to Prevent and Treat Rheumatoid Arthritis Status UNKNOWN Phase N/A
NCT04474392 Sputum Studies of Anti-Citrullinated Protein Antibodies (ACPA) and Rheumatoid Arthritis (RA) Origins Status COMPLETED Phase N/A
NCT04472390 Study of Tapering and Discontinuing Biological DMARDs in Rheumatoid Arthritis Patients Status UNKNOWN Phase N/A
NCT04470453 Association Between Methotrexate Erythrocyte Polyglutamate Concentration and Biological Drug Concentration and Clinical Response in Rheumatoid Arthritis Patients Treated With Subcutaneous Injectable Methotrexate and a First Biological Drug Status TERMINATED Phase PHASE4
NCT04464642 Tofacitinib Versus Methotrexate as the First Line DMARD in the Treatment of Rheumatoid Arthritis Status UNKNOWN Phase PHASE4
NCT04464096 Can Musculoskeletal Ultrasound Predict Fall Risk in Rheumatoid Arthritis Patients? Status COMPLETED Phase N/A
NCT04439682 The Effects of Exercise on Some Biochemical Parameters in Patients With Rheumatoid Arthritis Status UNKNOWN Phase NA
NCT04434118 Anti-rheumatic Drug Use and Risk of COVID-19 Infection in Rheumatoid Arthritis Patients Status WITHDRAWN Phase N/A
NCT04429776 Tapering of Biologics in Inflammatory Arthritis Patients in Remission Status ACTIVE_NOT_RECRUITING Phase NA
NCT04426747 Impact of Barriers and Facilitators to Physical Activity in Patients With Inflammatory Arthritis Status UNKNOWN Phase N/A
NCT04426279 Morbimortality of Covid-19 in Patients With Chronic Inflammatory Rheumatism Treated With Immunosuppressants Status TERMINATED Phase N/A
NCT04415502 CTHRC1: A Biomarker for Evaluation of Rheumatoid Arthritis Disease Activity Status UNKNOWN Phase N/A